|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1999-11-30
|
|
pubmed:abstractText |
Arterial diameter changes in response to flow. Chronic flow-mediated arterial enlargement may be mediated through metalloproteinase activity in the extracellular matrix of the arterial wall. We examined flow-mediated enlargement in the setting of increasing competitive matrix metalloproteinase (MMP) inhibition and with respect to gelatinase A and B expression and activity.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0022-4804
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 1999 Academic Press.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
87
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
122-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10527713-Animals,
pubmed-meshheading:10527713-Arteries,
pubmed-meshheading:10527713-Arteriovenous Shunt, Surgical,
pubmed-meshheading:10527713-Dose-Response Relationship, Drug,
pubmed-meshheading:10527713-Enzyme Inhibitors,
pubmed-meshheading:10527713-Male,
pubmed-meshheading:10527713-Matrix Metalloproteinase 2,
pubmed-meshheading:10527713-Matrix Metalloproteinase 9,
pubmed-meshheading:10527713-Matrix Metalloproteinases,
pubmed-meshheading:10527713-Pyrans,
pubmed-meshheading:10527713-Rats,
pubmed-meshheading:10527713-Rats, Sprague-Dawley,
pubmed-meshheading:10527713-Vasodilation
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Dose-dependent limitation of arterial enlargement by the matrix metalloproteinase inhibitor RS-113,456.
|
|
pubmed:affiliation |
Vascular Section, Veterans Affairs Palo Alto Health Care System, Palo Alto, California 94303, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
